Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.

NCT01039350 is registered in ClinicalTrials.gov with Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon as lead sponsor.

NCT NCT01039350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01039350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
Lead sponsor
Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2006
Completion date
July 31, 2009
Enrollment
80 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome